Images are for illustrative purposes only.
Semaglutide
Semaglutide is a long-acting GLP-1 (glucagon-like peptide-1) receptor agonist, supplied here as unformulated peptide for laboratory research. Its structure carries a C18 fatty di-acid chain that drives albumin binding, the feature behind the extended half-life examined in pharmacokinetic work.
In vitro and preclinical research centers on GLP-1 receptor binding and activation, glucose-dependent insulin secretion, glucagon suppression, gastric-emptying signaling, and central appetite and energy-balance pathways. As a single-receptor agonist, semaglutide is the reference point against which researchers benchmark the dual agonist tirzepatide and the triple agonist retatrutide. Supplied as a lyophilized 10-vial kit in 10mg and 20mg sizes for in vitro research use only.